Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Position in Intuitive Surgical, Inc. $ISRG

Banco Bilbao Vizcaya Argentaria S.A. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% in the 2nd quarter, Holdings Channel.com reports. The fund owned 42,757 shares of the medical equipment provider’s stock after buying an additional 957 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Intuitive Surgical were worth $23,222,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of ISRG. Tobam grew its position in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares during the last quarter. TD Capital Management LLC raised its holdings in shares of Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the last quarter. 1248 Management LLC acquired a new stake in shares of Intuitive Surgical during the first quarter worth $30,000. Princeton Global Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth $30,000. Finally, Bank of Jackson Hole Trust grew its holdings in shares of Intuitive Surgical by 70.5% during the first quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 31 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Mizuho set a $575.00 price objective on Intuitive Surgical in a research note on Wednesday, October 22nd. Argus lifted their target price on Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. Raymond James Financial set a $603.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Finally, UBS Group set a $600.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Insider Buying and Selling

In other news, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This represents a 59.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 116,164 shares of company stock valued at $61,916,172 in the last ninety days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 1.2%

Intuitive Surgical stock opened at $565.51 on Friday. The firm has a market cap of $202.72 billion, a PE ratio of 74.80, a P/E/G ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock’s 50 day simple moving average is $480.86 and its two-hundred day simple moving average is $502.93.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the previous year, the firm earned $1.84 EPS. The business’s quarterly revenue was up 22.9% on a year-over-year basis. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.